AZUSTAN-500 Tablets

MRP - 1,267.30

Azustan 500 contains Azithromycin, offering broad-spectrum macrolide coverage with excellent tissue penetration and superior bacterial eradication. Manufactured by ISO & WHO-GMP certified Lxir Medilabs in tablet and injection forms. A high-movement antibiotic for PCD pharma franchise partners expanding their anti-infective range. Rx only — use under medical supervision.

BrandAzustan-500
CompositionAZITHROMYCIN 500MG
Pack Size10 X 5
Pack TypeBlister
Start Chat
Category:

Description

Azustan 500 — The Most Advanced Macrolide with Deepest Tissue Reach

Azustan combines the trusted efficacy of Azithromycin, available 500 mg tablet strengths, giving physicians flexibility across a wide range of bacterial infections. As a broad-spectrum macrolide with a long half-life and excellent tissue penetration, Azithromycin has demonstrated better bacterial eradication rates for respiratory pathogens compared to levofloxacin, along with strong clinical cure rates in tonsillopharyngitis. This clinical performance, combined with the convenience of short-course dosing that macrolides are known for, keeps Azithromycin among the most frequently prescribed antibiotics across general practice, making Azustan a high-movement molecule for franchise partners building their anti-infective range.

Consistency Across a Widely Prescribed Molecule

Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company headquartered in Panchkula, Haryana  with manufacturing carried out at our Baddi, Himachal Pradesh facility. A molecule as widely prescribed as Azithromycin demands tight batch-to-batch consistency, since even minor variation affects a physician’s confidence in day-to-day prescribing. Azustan is manufactured under strict quality control to ensure this reliability across both strengths, giving franchise partners a dependable product to introduce across general physicians, ENT specialists and pulmonologists. For a PCD pharma franchise company in India, offering both tablet and injection forms of a trusted molecule strengthens a field partner’s position with hospitals and institutional buyers alike.

Product Highlights for Franchise Partners

  • Composition: Azithromycin 500 mg
  • Dosage Form: Tablets (Azithromycin 500 mg Injection also available)
  • Indications: Pharyngitis, tonsillitis, acute bacterial sinusitis, acute otitis media, acute bacterial exacerbations of chronic bronchitis, community-acquired pneumonia, urethritis/cervicitis/genital ulcer, uncomplicated skin infections
  • Key Benefit: Broad-spectrum macrolide with excellent tissue penetration and superior bacterial eradication
  • Suited For: Distributors and medical representatives strengthening their anti-infective portfolio

Franchise partners looking to add a high-demand macrolide antibiotic across two strengths and dosage forms can explore this and other formulations through our PCD pharma franchise division, with complete promotional support.

Disclaimer: This is a prescription antibiotic and should be used strictly under the supervision of a registered medical practitioner.

Additional information

Brand

Azustan-500

Composition

AZITHROMYCIN 500MG

Pack Size

10 X 5

Pack Type

Blister